For the fourth quarter of 2024, the Company expects revenue of $910 million, plus or minus $40 million, Adjusted EBITDA of $226 million, plus or minus $23 million, and Non-GAAP net earnings per ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Nov. 07, 2024 ...

See the full GO 419 list of fun events below that are happening near you: Discover the rhythm of West African drumming and ...

If you have a strong riff or phrase, consider using this as part of your chorus. Think about the best choruses in history, ...

On November 5, it was revealed in an SEC filing that Yin C Becker, VP at Stryker SYK executed a significant exercise of company stock options.

In the case of Bhushan Ishwar Mahajan Vs. State of Maharashtra and others, the Bombay High Court heard a public interest ...

Beyoncé is urging her fans to cast their valuable votes in rare social media update after speaking at a Kamala Harris rally ...

Q3 2024 Earnings Call Transcript November 7, 2024 Pacific Biosciences of California, Inc. beats earnings expectations.

Reimagining the power of investing. Connecting people for a better world. The products, services, information and/or materials contained within these web pages may not be available for residents of ...

OraQuick® HCV Self-test receives initial orders following receipt of WHO pre-qualification status Expanding Sample Management applications into blood proteomics Exiting Risk Assessment testing ...

A substantial insider sell was reported on November 7, by Ronda E Stryker, Board Member at Stryker SYK, based on the recent SEC filing. What Happened: According to a Form 4 filing with the U.S.